These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor. Coplen DE; Marcus MD; Myers JA; Ratliff TL; Catalona WJ J Urol; 1990 Sep; 144(3):652-7. PubMed ID: 2388321 [TBL] [Abstract][Full Text] [Related]
12. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra. Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432 [TBL] [Abstract][Full Text] [Related]
13. Miliary tuberculosis after intravesical bacille Calmette-Guérin immunotherapy for carcinoma of the bladder. Rabe J; Neff KW; Lehmann KJ; Mechtersheimer U; Georgi M AJR Am J Roentgenol; 1999 Mar; 172(3):748-50. PubMed ID: 10063874 [No Abstract] [Full Text] [Related]
15. [Intravesical immunotherapy of in situ carcinoma of the urinary bladder using Bacillus Calmette-Guerin (BCG)]. Jakse G Wien Klin Wochenschr; 1987 Feb; 99(4):114-8. PubMed ID: 3577186 [TBL] [Abstract][Full Text] [Related]
16. Long-term Survival Outcomes With Intravesical Nanoparticle Albumin-bound Paclitaxel for Recurrent Non-muscle-invasive Bladder Cancer After Previous Bacillus Calmette-Guérin Therapy. Robins DJ; Sui W; Matulay JT; Ghandour R; Anderson CB; DeCastro GJ; McKiernan JM Urology; 2017 May; 103():149-153. PubMed ID: 28163086 [TBL] [Abstract][Full Text] [Related]
17. Purified Protein Derivative Skin test prior to bacillus Calmette-Guérin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer. Niwa N; Kikuchi E; Matsumoto K; Kosaka T; Mizuno R; Oya M J Urol; 2018 Jun; 199(6):1446-1451. PubMed ID: 29307686 [TBL] [Abstract][Full Text] [Related]
18. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer. Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D Prog Clin Biol Res; 1989; 310():325-34. PubMed ID: 2672020 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary disease following intravesical BCG treatment. Kesten S; Title L; Mullen B; Grossman R Thorax; 1990 Sep; 45(9):709-10. PubMed ID: 2218978 [TBL] [Abstract][Full Text] [Related]
20. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer]. Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]